- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about FDA Grant
Recent news which mentions FDA Grant
Jasper Shares Climb As FDA Grants Fast Track Status To Immunodeficiency Disease Candidate
September 15, 2022
Tickers
JSPR
From Benzinga
Kymera Gets Orphan Drug Status For Rare Blood Cancer Candidate
September 15, 2022
Tickers
KYMR
From Benzinga
FDA Grants Orphan Drug Status To Centessa's Hemophilia B Candidate
September 14, 2022
Tickers
CNTA
From Benzinga
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
September 13, 2022
Tickers
GNFT
From Benzinga
Syros Shares Soar As FDA Grants Orphan Drug Status To Pancreatic Cancer Candidate
September 13, 2022
Tickers
SYRS
From Benzinga
aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate
September 13, 2022
Tickers
LIFE
From Benzinga
Mersana Shares Climb As FDA Grants Fast Track Status To Triple-Negative Breast Cancer Candidate
September 12, 2022
Tickers
MRSN
From Benzinga
Silence Therapeutics Gets FDA Fast Track Status For Blood Cancer Candidate
September 08, 2022
Tickers
SLN
From Benzinga
Pfizer Gets FDA Breakthrough Therapy Designation For GBS Vaccine Candidate
September 07, 2022
Tickers
PFE
From Benzinga
Intellia Gets FDA Orphan Drug Status For Hereditary Angioedema Candidate
September 01, 2022
Tickers
NTLA
From Benzinga
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Tickers
LGVN
From Benzinga
BioCryst Secures FDA Orphan Drug Status For Rare Connective Tissue Disease Candidate
August 31, 2022
Tickers
BCRX
From Benzinga
ALX Oncology Shares Gain As FDA Grants Fast Track Status To Head And Neck Cancer Candidate
August 01, 2022
Tickers
ALXO
From Benzinga
Olema Oncology Shares Ascend As FDA Grants Fast Track Status To Breast Cancer Candidate
July 21, 2022
Tickers
OLMA
From Benzinga
Karyopharm Shares Soar On FDA Fast Track Status, EU Orphan Medicinal Product Status To Preleukemia Candidate
July 20, 2022
Tickers
KPTI
From Benzinga
Amryt Shares Shoot Higher As FDA Grants Orphan Drug Status To Carcinoid Tumor Candidate
July 14, 2022
Tickers
AMYT
From Benzinga
Kazia Shares Shoot Higher As FDA Grants Rare Pediatric Disease Designation To Brain Cancer Candidate
July 06, 2022
Tickers
KZIA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.